TauRx Sponsors AAIC 2023

TauRx is a proud sponsor of AAIC 2023 where we can connect and collaborate with colleagues, share important clinical updates on the recently completed LUCIDITY Phase 3 trial, and support advances for people living with Alzheimer's.

We are supporting two important sessions and will be available to discuss LUCIDITY throughout the week.

Developing Topics #83153 - Oral Presentation: Signi­ficant dose-dependent reduction in neuro­filament light chain concentration in plasma with oral tau aggregation inhibitor hydromethylthionine mesylate (data results from LUCIDITY Phase 3 clinical trial) - Presented by Professor Claude Wischik, Co-Founder, Chairman and Chief Executive, TauRx Pharmaceuticals Ltd on Sunday, 16 July: 8:00 – 8:45 am CEST, RAI Amsterdam Convention Centre, Hall 12.

Sponsored Symposium: Wake Up...it's time for a new AD healthcare system! Panel discussion moderated by Dr. Serge Gauthier, Monday, 17 July: 6:15 – 7:45 am CEST, Hotel Okura Amsterdam, Grand Ballroom (Breakfast will be served).

TauRx and GT Diagnostics will be at Exhibit Booth 205 and look forward to meeting with delegates over the course of the event.

If you are attending the event, please look out for our communications providing details of how to arrange an in-person or virtual meeting.